This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
By integrating digitization and machine learning, there is an opportunity to deliver personalized care to all patients and scale precision dosing with minimal physician involvement, maximizing the effectiveness and accessibility of these drugs. appeared first on MedCity News.
Graphite Bio voluntarily paused a Phase 1/2 test of its gene-edited therapy for sickle cell disease after the first patient in the study developed a serious blood complication. The setback will also delay plans to reach the clinic with another genetic medicine in its pipeline.
Pharma DTC marketing is unique, and drug marketers need to think more about the journey from awareness to requesting an Rx. In addition, the patient journey is different for each product category and audience. The hottest pharma product is Lilly’s diabetes drug, hyped by the media as helping patients lose weight.
Tik-Tok, Instagram, and other social media channels may soon be overwhelmed with pharma companies’ content, but is it a good idea? Pharma companies have policies that heavily restrict their use of social media and limit their ability to benefit from the wealth of data that could accompany it.
Corticosteroids are a standard first-line treatment for Duchenne muscular dystrophy, but these drugs have many sideeffects. FDA approval of Italfarmaco’s Duvyzat is the first nonsteroidal drug to pass the agency’s regulatory bar for treating this rare disease.
SUMMARY: People are going online more and more to sarch for health information after seeing a DTC pharma TV spot. Pharma websites are not consdiered a top resource for infromation on new products. It’s more about weighing the benefit against the potential sideeffects. In the past, the cost was a key issue.
For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the sideeffects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.
Walk into any corporate pharma HQ, and you’re likely to see a mission statement that’s pure b t about how patients come first. We all know that Wall Street and sales come well before patients. Just look at any pharma product website that is nothing but a sales brochure in a majority of cases. Want proof?
Can pharma leverage influencer marketing? Google Trends has reported that the top search terms for Wegovy besides weight loss are “Wegovy cost” and “Wegovy sideeffects.” Influencers have already been talking about pharma. The post Influencer marketing in pharma. billion in 2021.
In fact, the research shows that those who were on semaglutide were less likely to have suicidal thoughts than patients on other diabetes and obesity meds.
BCMA-targeted therapies are transforming care for multiple myeloma patients. But these immunotherapies also come with various potentially dangerous sideeffects. |
Could cautions about more common sideeffects soon be added to the labels of popular treatments such as Novo’s Ozempic and Lilly’s Mounjaro? On Tuesday, the FDA revealed that it is investigating patient reports of suicidal thoughts and hair loss from the use of the blood sugar-modulating products.
Product websites are stagnant, and online health seekers are going elsewhere to learn about your medication’s sideeffects and cost. A website and TV commercials are not enough to get patients to ask for a prescription medication especially when fair balance lists sideeffects like cancer.
We’re moving from an era of “promotional marketing” to an age of “data is key” and “helping patients become consumers of healthcare.” 70% of HCPs said that pharma representatives do not understand their requirements completely. ” HCP’s are moving quickly into digital.
Consumers have changed their shopping behavior due to the pandemic, and some of those changes are relevant for pharma marketers. When examing pharma DTC a lot has changed from the model of awareness to Rx. Two doctors I chatted with said they are getting requests from patients who want to lose weight and do not have diabetes.
Will patients, who are obese and don’t have Type 2 diabetes, ask for the drug for weight loss, and will patients understand the risks? Mounjaro, Lilly’s new diabetes drug, is sure to be in high demand initially after launch, but patients should be aware of its sideeffects. A matter of trust?
However, with pharma brands, online is essential to a successful marketing strategy. Part of that online experience is going to the pharma product website, but too many marketers feel that is a good indication that people will ask for their product. They’re going online to learn about sideeffects, costs, and benefits.
DTC marketers spend a lot of time and money gaining insights into patients and caregivers. That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients. The research showed that patients wanted to understand how the drug works and the potential sideeffects.
SUMMARY: Big pharma is still using outdated bureaucratic processes for everything from hiring to implementing marketing tactics to the point the industry is becoming more bloated. How long does it take to hire a new pharma employee? The post Big, bureaucratic pharma appeared first on World of DTC Marketing.com. and 6 weeks?
A number of factors impact health literacy, including a patient’s receipt of appropriate written health communication materials, ability to accurately interpret written health-related information, and communication with providers. For example, such communication barriers have been associated with patients being more likely to be hospitalized.
Imagine a time when pharmaceutical ads simply told patients what to ask their doctor. Today, patient marketing is no longer a one-way street. For pharma marketing executives and brand teams, understanding this evolution is essential to remaining competitive and compliant in a rapidly shifting healthcare environment.
But with strict regulations and evolving consumer expectations, how do pharma brands navigate the digital landscape effectively? Pharma professionals should take the time to research and segment their audience. Are you trying to engage healthcare professionals (HCPs), patients, or caregivers?
THOUGHT: I love working in the pharma industry. During one weekly status call, the Medical Affairs person commented that they were receiving reports from “the field” of a new sideeffect not listed in the label. Every pharma CEO should require that every employee has a KRA on focusing on patients.
Consistently we heard that they like images of real patients or a REAL doctor with one key message communicated. In clinical trials, how many people experienced a listed sideeffect? 7even: Real patient stories. 9ine: “Why aren’t pharma websites updated?” First impressions are 94% design-related.
From promoting blockbuster drugs like Humira to leveraging new technologies, pharma marketing executives need actionable strategies to succeed in a rapidly evolving landscape. Crafting Effective Pharmaceutical Advertising Campaigns Pharmaceutical advertising thrives on delivering value.
Here are some myths around DTC marketing: 1ne: DTC ads result in patients asking for prescriptions they don’t need. 3hree: DTC marketing minimizes the sideeffects of prescription drugs – One of the top pages within prescription drug websites continues to be “safety information.”
Nowhere is this clearer than in pharma DTC TV ads. A Prevention Magazine study dated had prescription DTC ads as being 7% effective in driving new Rx’s. Each disease state has unique patient behaviors, and decision matrix’s for going from awareness to asking for an Rx. viewers still see linear T.V.
Jazz Pharmaceuticals has introduced a new prescription medication for patients with sleep apnea/narcolepsy that “helped adults get up to 9 hours of improved wakefulness in clinical studies at 12 weeks” and they’re using a flying pig on their DTC. billion in 2018, and is expected to grow at a CAGR of 7.20% to reach $86.01
In today’s digital-first world, Pay Per Click (PPC) advertising has become an essential strategy for pharma marketing executives. Why PPC Matters in Pharma Marketing Why invest in PPC? In a world where patients and healthcare professionals (HCPs) search for drug information online, PPC lets you stay top-of-mind.
The companies aim to bring patients drugs that offer the benefit of psychedelics but with a better sideeffect profile. AbbVie’s alliance with Gilgamesh Pharmaceuticals is pursuing next-generation psychiatric medications.
With millions of healthcare professionals (HCPs) and patients turning to Google for medical information, paid search ads present a huge opportunity for pharma brands to boost engagement and conversions. So, how can pharma marketing teams maximize the impact of their Google Ads while staying compliant?
I just finished an analysis of a pharma clients website using their analytics. When online health seekers come to a pharma product website they want to know “what’s in it for me?” I see that online health seekers are listening to other patients to learn about drug sideeffects.
SUMMARY: AI in the pharma industry has the ability to transform certain capabilities. Precision medicine or next-generation sequencing helps in the faster discovery of drugs and tailored medication for individual patients. . AI may predict the questions patients and physicians have about a drug or its sideeffects.
What if the next patient who needs your medication is already searching onlineand youre not there? In today’s competitive healthcare landscape, PPC campaigns (Pay-Per-Click advertising) have emerged as a critical lever for pharma marketers aiming to deliver timely, targeted, and measurable impact.
One of the most effective tools for marketing executives is display advertising. One of the most effective tools for marketing executives is display advertising. But how can pharma marketers harness its full potential? Why Display Advertising Matters in Pharma In pharma, the stakes are high.
SUMMARY : DTC marketing is evolving as patients become more thoughtful about choosing treatment options. I hear more and more from top pharma clients that “our DTC ROI is not where we want it to be.” 6ix: Data is crucial even to patients. 7even : Beware the PR trap.
Following the impact of the COVID pandemic in 2020, patient engagement has become the focus area for more than half of healthcare chief information officers (CIOs). At the same time, patient portals have always been considered one of the most efficient tools for patient engagement. Explaining Medication Action.
Traditional outreach methods are no longer enough to engage healthcare professionals (HCPs) and patients in a digital-first world. But heres the challenge pharma PPC isnt like other industries. So how can pharma brands maximize their return on investment (ROI) while ensuring compliance with FDA and HIPAA regulations ?
However, patient uptake hasn’t matched rising market competition. And among patients who have tried preventive medications for migraine, 39% said they no longer took them. These low adoption rates highlight the need for more migraine-drug awareness and suggest that pharma marketers should explore new strategies to boost patient uptake.
DTC marketers would like to think that patients ask for the advertised drug when visiting their doctor, but that’s largely untrue. While it’s true that traffic on pharma websites is good, how these websites affect behavior has changed. Online searches for health information remain brisk, according to Google.
” So, are we supposed to believe that better images in DTC ads lead to patients asking for an Rx? Some of these studies associated information seeking more strongly with patients with chronic conditions and those with a more positive view of DTC advertising. What people seem to be interested in are drug sideeffects vs. efficacy.
DTC marketers who believe that DTC is essentially the same as before the pandemic are failing to recognize significant shifts in patient behavior regarding prescription drugs. Any discussion around DTC should acknowledge the following: 1ne: DTC is more effective for some health categories than others. What are the sideeffects?
This approval was NOT about patients; it was about the profits of a pharma company in quicksand and sinking fast. They moved into an expensive new HQ in Cambridge, and other pharma companies developed competing MS therapies that left Biogens in the dust. ” Folks, it doesn’t get any worse than this.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content